297 related articles for article (PubMed ID: 25937098)
1. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
El-Asrar AM; Struyf S; Kangave D; Al-Obeidan SS; Opdenakker G; Geboes K; Van Damme J
Clin Immunol; 2011 May; 139(2):177-84. PubMed ID: 21334264
[TBL] [Abstract][Full Text] [Related]
4. Natural Killer Cell Subsets and Their Functional Activity in Behçet's Disease.
Cosan F; Aktas Cetin E; Akdeniz N; Emrence Z; Cefle A; Deniz G
Immunol Invest; 2017 May; 46(4):419-432. PubMed ID: 28388249
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells control a T-helper 1 response in patients with Behçet's disease.
Yamaguchi Y; Takahashi H; Satoh T; Okazaki Y; Mizuki N; Takahashi K; Ikezawa Z; Kuwana M
Arthritis Res Ther; 2010; 12(3):R80. PubMed ID: 20459787
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
10. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Park JY; Chung YR; Lee K; Song JH; Lee ES
Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Th Cell-related Cytokine Production in Behçet Disease Patients with Uveitis Before and After Infliximab Treatment.
Takeuchi M; Karasawa Y; Harimoto K; Tanaka A; Shibata M; Sato T; Caspi RR; Ito M
Ocul Immunol Inflamm; 2017 Feb; 25(1):52-61. PubMed ID: 27070371
[TBL] [Abstract][Full Text] [Related]
12. An elevated pro-inflammatory cytokines profile in Behcet's disease: A multiplex analysis.
Gholijani N; Ataollahi MR; Samiei A; Aflaki E; Shenavandeh S; Kamali-Sarvestani E
Immunol Lett; 2017 Jun; 186():46-51. PubMed ID: 27939191
[TBL] [Abstract][Full Text] [Related]
13. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
14. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
15. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
16. IL-2/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model.
Choi JY; Choi B; Shim JA; Lee ES; Kim DY; Bang D; Sohn S
Immunobiology; 2015 Dec; 220(12):1381-92. PubMed ID: 26213097
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
18. Circulating NK cells and their subsets in Behçet's disease.
Hasan MS; Ryan PL; Bergmeier LA; Fortune F
Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory cellular immune response in Behçet's disease.
Kulaber A; Tugal-Tutkun I; Yentür SP; Akman-Demir G; Kaneko F; Gül A; Saruhan-Direskeneli G
Rheumatol Int; 2007 Oct; 27(12):1113-8. PubMed ID: 17549482
[TBL] [Abstract][Full Text] [Related]
20. Th1 polarization of the immune response in uveitis in Behçet's disease.
Ilhan F; Demir T; Türkçüoğlu P; Turgut B; Demir N; Gödekmerdan A
Can J Ophthalmol; 2008 Feb; 43(1):105-8. PubMed ID: 18204495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
